Monsieur KHUDER ALAGHA / PhD

Publications

• Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial
  Clin Exp Allergy, 2012
  Nair P, Gaga M, Zervas E, Alagha K, Hargreave FE, O'Byrne PM, Stryszak P, Gann L, Sadeh J, Chanez P
  http://www.ncbi.nlm.nih.gov/pubmed/22702508
  
• An update on the efficacy and safety of aclidinium bromide in patients with COPD
  Ther Adv Respir Dis, 2010
  Alagha K, Tummino C, Bourdin A, Chanez P
  http://www.ncbi.nlm.nih.gov/pubmed/20884687
  
• Iatrogenic eosinophilic pleural effusion
  Eur Respir Rev, 2011
  Alagha K, Tummino C, Sofalvi T, Chanez P
  http://www.ncbi.nlm.nih.gov/pubmed/21632800
  
• Phénotypes de l'asthme
  La revue du praticien, 2010
  Chanez P, Alagha K, Bourdin A
  http://www.ncbi.nlm.nih.gov/pubmed/20402116
  
• Definitions de l'asthme : notion de sévèrité et de contrôle
  Revue Praticien, 2011
  Chanez P, Tummino C, Gouitaa M, Alagha k, Bourdin A
  http://www.ncbi.nlm.nih.gov/pubmed/21563403
  
• Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases
  Ther Adv Respir Dis., 2013
  Alagha K, Palot A, Sofalvi T, Pahus L, Gouitaa M, Tummino C, Martinez S, Charpin D, Bourdin A, Chanez P
  
  
• Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults.
  Eur Respir Rev, 2014
  Alagha K, Dombret MC, Philippe Boulet L, Yves Brillet P, Joos G, Laviolette M, Louis R, Rochat T, Soccal P, Aubier M, Chanez P.
  http://www.ncbi.nlm.nih.gov/pubmed/25445950
  
• Bilateral diaphragmatic paralysis due to Parsonage-Turner syndrome
  Revue des maladies respiratoires, 2014
  Tissier-Ducamp D, Martinez S, Alagha K, Charpin D, Chanez P, Palot A.
  http://www.ncbi.nlm.nih.gov/pubmed/25534571
  
• Persistent severe hypereosinophilic asthma is not associated with airway remodeling.
  Respiratory Medicine, 2015
  Alagha K, Jarjour B, Bommart S, Aviles B, Varrin M, Gamez AS, Molinari N, Vachier I, Paganin F, Chanez P, Bourdin A.
  http://www.ncbi.nlm.nih.gov/pubmed/25592243
  
• Tobacco smoke in infants with bronchopulmonary dysplasia.
  European journal of pediatrics, 2015
  Martinez S, Garcia-Meric P, Millet V, Aymeric-Ponsonnet M, Alagha K, Dubus JC.
  http://www.ncbi.nlm.nih.gov/pubmed/25633581
  
• We should prohibit warfarin in idiopathic pulmonary fibrosis.
  American Journal of Respiratory and Critical Care Medicine, 2015
  Alagha K, Secq V, Pahus L, Sofalvi T, Palot A, Bourdin A, Chanez P.
  http://www.ncbi.nlm.nih.gov/pubmed/25876206
  
• External Validity of Randomized Controlled Trials in Severe Asthma.
  American Journal of Respiratory and Critical Care Medicine, 2015
  Pahus L, Alagha K, Sofalvi T, Vachier I, Bourdin A, Molinari N, Chanez P; COBRA consortium.
  http://www.ncbi.nlm.nih.gov/pubmed/26177176
  
• Warfarin leads to acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) but probably not to worsening pulmonary fibrosis in Idiopathic Pulmonary Fibrosis (IPF).
  american Journal of Respiratory and Critical Care Medicine, 2015
  Khuder Alagha, Arnaud Bourdin, Pascal Chanez